Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Objective confirmation of asthma diagnosis improves medication adherence

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Overweight in childhood and adolescence: Does it lead to airway hyperresponsiveness in adulthood?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Novel monoclonal treatments in severe asthma

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. Stability of FeNO and airway hyperresponsiveness to mannitol in untreated asthmatics

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Are recreational SCUBA divers with asthma at increased risk?

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  5. Bronchial provocation testing does not detect exercise-induced laryngeal obstruction

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Characteristics and treatment regimens across ERS SHARP severe asthma registries

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Primary ciliary dyskinesia patients have the same P. aeruginosa clone in sinuses and lungs

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. The risk of asthma is increased among women with polycystic ovary syndrome: a twin study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

OBJECTIVE: The impact of diagnostic work-up in asthma management on medication redemption and probably also drug adherence is largely unknown, but we hypothesized that a confirmed diagnosis of asthma in a hospital-based out-patient clinic increases the willingness to subsequent medication redemption in a real life setting.

METHODS: In a retrospective register-based study, 300 medical records of patients referred with possible asthma during one year were examined, of whom 171 had asthma (57%). One-year data on dispensed medicine was collected using the Danish Registry of Medicinal Product Statistics. Patients who had a positive asthma (e.g. bronchial challenge) were classified as verified asthma, whereas unverified asthma refers to doctor's diagnosis of asthma with negative or no diagnostic tests performed.

RESULTS: 111 (65%) had a verified diagnosis and patients with verified asthma were more frequently prescribed new therapy compared to those with unverified asthma (88.9% vs. 65.0%, respectively, p < 0.001). No difference was found in first time redemption of prescriptions (72% vs. 64%, respectively, p = 0.3), whereas the second (52% vs. 27%, p = 0.001) and third or more asthma redeemed prescriptions (37% vs. 17%, p = 0.006) showed increased redemption of prescription and probably adherence in the verified compared with the unverified patients with asthma. Furthermore, the use of inhaled corticosteroid (ICS) was calculated as Percent Days Covered (PDC), which was higher in the verified group compared with the non-verified asthma group (88% vs. 30%, p = 0.004).

CONCLUSION: Objective verification of a diagnosis of asthma using asthma tests was associated with an improved redemption of prescription.

OriginalsprogEngelsk
TidsskriftThe Journal of asthma : official journal of the Association for the Care of Asthma
Vol/bind55
Udgave nummer11
Sider (fra-til)1262-1268
Antal sider7
ISSN0277-0903
DOI
StatusUdgivet - 2018

ID: 52382403